Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT06071052What this trial is testingTACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment RegimensWho this might be right forLiver Metastasis Colon Cancer First Affiliated Hospital, Sun Yat-Sen University 21
Testing effectiveness (Phase 2)Ended earlyNCT05551117What this trial is testingVobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsWho this might be right forCastration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more MacroGenics 192
Early research (Phase 1)Study completedNCT00635596What this trial is testingPhase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian CancerWho this might be right forSolid Tumors Amgen Research (Munich) GmbH 65
Early research (Phase 1)Ended earlyNCT02408861What this trial is testingNivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more National Cancer Institute (NCI) 79
Early research (Phase 1)Study completedNCT00449137What this trial is testingArsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to TreatmentWho this might be right forColorectal Cancer University of Miami 13
Early research (Phase 1)Ended earlyNCT02313012What this trial is testingSafety and PK Study of CC-90003 in Relapsed/Refractory Solid TumorsWho this might be right forNeoplasm Metastasis Celgene 19
Not applicableStudy completedNCT01996969What this trial is testingIdentification of Predictive Biomarker of Regorafenib in Refractory Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Seoul National University Hospital 117
Testing effectiveness (Phase 2)Looking for participantsNCT05093907What this trial is testingEvaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer BeyondBio Inc. 27
Testing effectiveness (Phase 2)Study completedNCT03475004What this trial is testingStudy of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer University of Colorado, Denver 53
Testing effectiveness (Phase 2)Ended earlyNCT04786600What this trial is testingA Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 TrialWho this might be right forMetastatic Colorectal Cancer University of Florida 6
Early research (Phase 1)Ended earlyNCT04348916What this trial is testingStudy of ONCR-177 Alone and in Combination With PD-1 Blockade in Adult Subjects With Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors or With Liver Metastases of Solid TumorsWho this might be right forCancerMelanomaSolid Tumor+7 more Oncorus, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT00313794What this trial is testingStudy of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After TreatmentWho this might be right forColorectal Neoplasms AstraZeneca 49
Early research (Phase 1)Study completedNCT02116894What this trial is testingSafety Study of Regorafenib With PF-03446962 to Treat Colorectal CancerWho this might be right forColorectal Cancer Duke University 11
Testing effectiveness (Phase 2)Looking for participantsNCT07012954What this trial is testingCtDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRCWho this might be right forColorectal Cancer Metastatic Sun Yat-sen University 64
Early research (Phase 1)Looking for participantsNCT06102902What this trial is testingTesting the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal CancerWho this might be right forMetastatic Colorectal AdenocarcinomaRecurrent Colorectal AdenocarcinomaRefractory Colorectal Adenocarcinoma+1 more National Cancer Institute (NCI) 30
Early research (Phase 1)Ended earlyNCT01285102What this trial is testingChemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal CancerWho this might be right forLiver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more Fox Chase Cancer Center 4
Testing effectiveness (Phase 2)UnknownNCT04695470What this trial is testingPhase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer PatientsWho this might be right forColorectal Cancer Aiping Zhou 70
Not applicableStudy completedNCT04920422What this trial is testingRE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins.Who this might be right forMetastatic Colorectal Cancer Bayer 242
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07510932What this trial is testingFruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K)Who this might be right forColon Cancer Korea University Anam Hospital 88